Strides Pharma Science Ltd
STARStrides Pharma Science Ltd
STAR


Price Chart
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
27.26 | 3.27 | 0.34% |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
50.00 | 6.36 | 0.53% |
Forecast & Ratings
Detailed Forecast from 3 analysts
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Strides Pharma Science is a vertically integrated global pharmaceutical company engaged in the development and manufacturing of active pharmaceutical ingredients and formulations, as well as biotech
Peers
Compare with peersÂGet more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 2,961.59 | 3,097.80 | 3,534.85 | 2,545.66 | 2,909.44 | 3,518.84 | 3,259.23 | 3,935.35 | 4,145.60 | 4,526.37 | ||||||||||
Raw Materials | 1,612.38 | 1,432.25 | 1,286.65 | 1,189.20 | 1,167.29 | 1,686.50 | 1,407.04 | 1,629.55 | 1,624.56 | 3,729.66 | ||||||||||
Power & Fuel Cost | 77.18 | 33.87 | 51.33 | 54.39 | 64.49 | 64.58 | 71.54 | 85.82 | 86.48 | |||||||||||
Employee Cost | 357.70 | 419.16 | 434.05 | 329.44 | 442.56 | 550.15 | 646.91 | 732.02 | 751.13 | |||||||||||
Selling & Administrative Expenses | 323.35 | 339.47 | 409.34 | 276.20 | 338.51 | 473.78 | 577.98 | 526.31 | 477.75 | |||||||||||
Operating & Other expenses | 154.11 | 54.45 | 313.14 | 196.74 | 525.25 | 98.10 | 798.52 | 724.88 | 733.28 | |||||||||||
EBITDA | 436.87 | 818.60 | 1,040.34 | 499.69 | 371.34 | 645.73 | -242.76 | 236.77 | 472.40 | 796.71 | ||||||||||
Depreciation/Amortization | 131.25 | 126.15 | 154.04 | 117.39 | 173.70 | 206.29 | 233.01 | 243.25 | 220.68 | 195.22 | ||||||||||
PBIT | 305.62 | 692.45 | 886.30 | 382.30 | 197.64 | 439.44 | -475.77 | -6.48 | 251.72 | 601.49 | ||||||||||
Interest & Other Items | 168.17 | 183.10 | 196.24 | 79.29 | 155.72 | 150.07 | 176.74 | 261.14 | 314.45 | 286.55 | ||||||||||
PBT | 137.45 | 509.35 | 690.06 | 303.01 | 41.92 | 289.37 | -652.51 | -267.62 | -62.73 | 314.94 | ||||||||||
Taxes & Other Items | 28.92 | 109.60 | 25.55 | -21.60 | 5.53 | 20.94 | -192.30 | -65.00 | 7.89 | 66.76 | ||||||||||
Net Income | 108.53 | 399.75 | 664.51 | 324.61 | 36.39 | 268.43 | -460.21 | -202.62 | -70.62 | 248.18 | ||||||||||
EPS | 6.18 | 18.97 | 31.50 | 15.63 | 1.78 | 13.12 | -22.47 | -9.86 | -3.40 | 11.83 | ||||||||||
DPS | 2.12 | 1.91 | 0.85 | 1.31 | 6.13 | 1.10 | 0.00 | 0.66 | 1.10 | 1.09 | ||||||||||
Payout ratio | 0.34 | 0.10 | 0.03 | 0.08 | 3.45 | 0.08 | 0.00 | — | — | 0.09 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Strides Pharma Science Ltd | -95.81 | 3.27 | 0.34% |
Sun Pharmaceutical Industries Ltd | 43.40 | 6.19 | 0.78% |
Cipla Ltd | 28.59 | 4.40 | 0.89% |
Torrent Pharmaceuticals Ltd | 65.24 | 15.76 | 0.88% |
Price Comparison
Compare STAR with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
High Pledged Promoter Holding
A significant proportion of promoter holdings is pledged
Institutional Holdings Trend
Increased Total Retail Holding
In last 3 months, retail holding in the company has increased by 2.12%
Decreased Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has decreased by 1.60%
Shareholding Pattern
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Strides Pharma Science Ltd
Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 3.3195% | Percentage of the fund’s portfolio invested in the stock 0.91% | Change in the portfolio weight of the stock over the last 3 months -1.10% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 34/98 (-21) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 1.4129% | Percentage of the fund’s portfolio invested in the stock 0.99% | Change in the portfolio weight of the stock over the last 3 months -1.20% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 20/67 (-6) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.7526% | Percentage of the fund’s portfolio invested in the stock 0.99% | Change in the portfolio weight of the stock over the last 3 months -0.18% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 64/81 (-4) |
Compare 3-month MF holding change on Screener
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateSep 9, 2024
Dividend/Share
₹2.50
Ex DateEx Date
Sep 9, 2024
Cash Dividend
Ex DateEx DateAug 4, 2023
Dividend/Share
₹1.50
Ex DateEx Date
Aug 4, 2023
Cash Dividend
Ex DateEx DateAug 5, 2021
Dividend/Share
₹2.50
Ex DateEx Date
Aug 5, 2021
Cash Dividend
Ex DateEx DateJul 24, 2020
Dividend/Share
₹2.00
Ex DateEx Date
Jul 24, 2020
Cash Dividend
Ex DateEx DateAug 22, 2019
Dividend/Share
₹12.00
Ex DateEx Date
Aug 22, 2019
Strides Pharma Science announced the change in designation of Arun Kumar (DIN: 00084845) from Executive Chairperson to Non-Executive Chairperson of the Company effective 05 April 2025. Arun Kumar, Founder and Executive Chairperson of the Company, has served in various positions on the Board of Strides since its inception. His current appointment as Executive Director is expiring on 06 April 2025. Upon successful transition of executive responsibilities to Badree Komandur (who was appointed as Managing Director and Group CEO effective 01 June 2024) and the Leadership team at Strides, Arun has opted to assume the role of Non-Executive Chairperson effective 05 April 2025.Powered by Capital Market - Live
Strides Pharma Science has appointed Mukta Arora (DIN: 07225715) as Independent Director of the Company effective 01 February 2025. Powered by Capital Market - Live
Net profit of Strides Pharma Science rose 77.07% to Rs 87.95 crore in the quarter ended December 2024 as against Rs 49.67 crore during the previous quarter ended December 2023. Sales rose 14.71% to Rs 1153.67 crore in the quarter ended December 2024 as against Rs 1005.77 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales1153.671005.77 15 OPM %18.2312.87 - PBDT164.7068.49 140 PBT116.2819.04 511 NP87.9549.67 77 Powered by Capital Market - Live
Strides Pharma Science will hold a meeting of the Board of Directors of the Company on 30 January 2025.Powered by Capital Market - Live
OneSource Specialty Pharma (OneSource) is India's first specialty pharma Contract Development and Manufacturing Organization (CDMO). OneSource shall start trading on NSE and BSE from Friday, January 24, 2025 onwards, stated the company. Strides Pharma Science is engaged in developing and manufacturing a wide range of IP-led niche pharmaceutical products. It reported a consolidated net profit of Rs 93.23 crore in Q1 FY25 as against a net loss of Rs 131.34 crore posted in Q2 FY24. Revenue from operations grew 20.17% to Rs 1201.1 crore in the quarter ended September 2024. Powered by Capital Market - Live
Authum Investment & Infrastructure Ltd, Century Plyboards (India) Ltd, Tanla Platforms Ltd and Amber Enterprises India Ltd are among the other gainers in the BSE's 'A' group today, 01 January 2025.Strides Pharma Science Ltd surged 10.27% to Rs 727.55 at 11:46 IST. The stock was the biggest gainer in the BSE's 'A' group. On the BSE, 1.32 lakh shares were traded on the counter so far as against the average daily volumes of 78858 shares in the past one month. Authum Investment & Infrastructure Ltd spiked 9.59% to Rs 1867.15. The stock was the second biggest gainer in 'A' group. On the BSE, 6551 shares were traded on the counter so far as against the average daily volumes of 8287 shares in the past one month. Century Plyboards (India) Ltd soared 9.46% to Rs 808. The stock was the third biggest gainer in 'A' group. On the BSE, 67435 shares were traded on the counter so far as against the average daily volumes of 8175 shares in the past one month. Tanla Platforms Ltd exploded 9.29% to Rs 734.45. The stock was the fourth biggest gainer in 'A' group. On the BSE, 68543 shares were traded on the counter so far as against the average daily volumes of 46356 shares in the past one month. Amber Enterprises India Ltd added 6.08% to Rs 7844. The stock was the fifth biggest gainer in 'A' group. On the BSE, 24875 shares were traded on the counter so far as against the average daily volumes of 40408 shares in the past one month. Powered by Capital Market - Live
CARE Ratings Ltd, Avalon Technologies Ltd, Adani Green Energy Ltd and Easy Trip Planners Ltd are among the other losers in the BSE's 'A' group today, 04 December 2024.Strides Pharma Science Ltd lost 5.11% to Rs 1513.1 at 14:47 IST.The stock was the biggest loser in the BSE's 'A' group.On the BSE, 34509 shares were traded on the counter so far as against the average daily volumes of 30958 shares in the past one month.CARE Ratings Ltd crashed 4.56% to Rs 1430. The stock was the second biggest loser in 'A' group.On the BSE, 4186 shares were traded on the counter so far as against the average daily volumes of 11904 shares in the past one month.Avalon Technologies Ltd tumbled 4.55% to Rs 875. The stock was the third biggest loser in 'A' group.On the BSE, 53104 shares were traded on the counter so far as against the average daily volumes of 1.01 lakh shares in the past one month.Adani Green Energy Ltd dropped 3.66% to Rs 1264.35. The stock was the fourth biggest loser in 'A' group.On the BSE, 2.38 lakh shares were traded on the counter so far as against the average daily volumes of 6.83 lakh shares in the past one month.Easy Trip Planners Ltd corrected 3.53% to Rs 16.38. The stock was the fifth biggest loser in 'A' group.On the BSE, 52.31 lakh shares were traded on the counter so far as against the average daily volumes of 23.43 lakh shares in the past one month.Powered by Capital Market - Live
Strides Pharma Science has allotted 2,04,500 equity shares under ESOP. Consequent to above, the paid-up share capital of the Company has increased from Rs. 91,95,82,140 consisting of 9,19,58,214 equity shares of Rs. 10/- each to 92,16,27,140 consisting of 9,21,62,714 equity shares of Rs. 10/- each. Powered by Capital Market - Live
Strides Pharma Science has fixed 06 December 2024 as record date for r determining names of the equity shareholders of Strides who shall be entitled for allotment of equity shares by OneSource, as consideration under the scheme of arrangement. Powered by Capital Market - Live
Strides Pharma Science announced that its associate company, OneSource Specialty Pharma has successfully completed the fundraise activity and has allotted equity shares to the marquee domestic and international investors who participated in this issue. OneSource Specialty Pharma has allotted 6,277,909 fully paid up equity shares at a price of Rs 1,276/- (including a premium of Rs 1,275/-) per share on a private placement basis to marquee domestic and international investors. The total consideration received from the allotment stands at Rs 801 crore, valuing OneSource at a pre-money equity valuation of USD 1.65 billion. This milestone reinforces OneSource's strong positioning as India's first specialty pharma CDMO and its readiness for robust growth ahead of its proposed listing. Powered by Capital Market - Live
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 10.24%, vs industry avg of 9.04%
Decreasing Market Share
Over the last 5 years, market share decreased from 1.16% to 1.1%